Androgen receptor modulating compounds
US10118933B2 · kind B2 · utility
7Cited by
3References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 13, 2017 |
| Grant date | Nov 6, 2018 |
| Priority date | — |
| Expiry date | Apr 13, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present disclosure relates to compounds of formula (I), and pharmaceutically acceptable salts thereof. The present disclosure also relates to compositions and methods of treating comprising compounds of formula (I), and pharmaceutically acceptable salts thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.